News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
723,251 Results
Type
Article (40975)
Company Profile (267)
Press Release (681998)
Multimedia
Podcasts (82)
Webinars (17)
Section
Business (204689)
Career Advice (2026)
Deals (35536)
Drug Delivery (114)
Drug Development (81396)
Employer Resources (173)
FDA (16426)
Job Trends (14949)
News (346450)
Policy (32738)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2573)
Accelerated approval (38)
Adcomms (24)
Allergies (151)
Alliances (49575)
ALS (175)
Alzheimer's disease (1681)
Antibody-drug conjugate (ADC) (328)
Approvals (16711)
Artificial intelligence (538)
Autoimmune disease (166)
Automation (44)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (194)
Biotechnology (174)
Bladder cancer (167)
Brain cancer (59)
Breast cancer (651)
Cancer (4965)
Cardiovascular disease (411)
Career advice (1712)
Career pathing (37)
CAR-T (285)
CDC (49)
Celiac Disease (2)
Cell therapy (756)
Cervical cancer (37)
Clinical research (69748)
Collaboration (1751)
Company closure (4)
Compensation (1187)
Complete response letters (58)
COVID-19 (2716)
CRISPR (95)
C-suite (884)
Cystic fibrosis (144)
Data (6456)
Decentralized trials (2)
Denatured (25)
Depression (137)
Diabetes (511)
Diagnostics (6742)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (260)
Drug pricing (187)
Drug shortages (28)
Duchenne muscular dystrophy (240)
Earnings (90485)
Editorial (58)
Employer branding (21)
Employer resources (152)
Events (117703)
Executive appointments (991)
FDA (19631)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (24)
Funding (1509)
Gene editing (203)
Generative AI (44)
Gene therapy (615)
GLP-1 (979)
Government (4675)
Grass and pollen (6)
Guidances (385)
Healthcare (18889)
HIV (68)
Huntington's disease (47)
IgA nephropathy (85)
Immunology and inflammation (256)
Immuno-oncology (65)
Indications (131)
Infectious disease (3000)
Inflammatory bowel disease (196)
Inflation Reduction Act (14)
Influenza (123)
Intellectual property (258)
Interviews (316)
IPO (16645)
IRA (50)
Job creations (3643)
Job search strategy (1428)
JPM (57)
Kidney cancer (18)
Labor market (87)
Layoffs (547)
Leadership (33)
Legal (7951)
Liver cancer (92)
Longevity (17)
Lung cancer (670)
Lymphoma (385)
Machine learning (45)
Management (59)
Manufacturing (823)
MASH (166)
Medical device (13793)
Medtech (13854)
Mergers & acquisitions (19988)
Metabolic disorders (1296)
mRNA (159)
Multiple sclerosis (169)
NASH (16)
Neurodegenerative disease (331)
Neuropsychiatric disorders (89)
Neuroscience (2959)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4516)
Now hiring (69)
Obesity (610)
Opinion (266)
Ovarian cancer (170)
Pain (205)
Pancreatic cancer (237)
Parkinson's disease (291)
Partnered (33)
Patents (516)
Patient recruitment (521)
Peanut (60)
People (58978)
Pharmaceutical (62)
Pharmacy benefit managers (30)
Phase 1 (21739)
Phase 2 (30693)
Phase 3 (22881)
Pipeline (5828)
Policy (293)
Postmarket research (2564)
Preclinical (9215)
Press Release (64)
Prostate cancer (255)
Psychedelics (48)
Radiopharmaceuticals (290)
Rare diseases (885)
Real estate (5957)
Recruiting (70)
Regulatory (24636)
Reports (53)
Research institute (2394)
Resumes & cover letters (353)
Rett syndrome (29)
RNA editing (16)
RSV (81)
Schizophrenia (150)
Series A (249)
Series B (192)
Service/supplier (11)
Sickle cell disease (101)
Special edition (22)
Spinal muscular atrophy (158)
Sponsored (42)
Startups (3617)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (84)
The Weekly (55)
Vaccines (1018)
Venture capital (89)
Weight loss (389)
Women's health (98)
Worklife (19)
Date
Today (128)
Last 7 days (943)
Last 30 days (2761)
Last 365 days (29926)
2026 (4980)
2025 (30172)
2024 (35215)
2023 (40075)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (736)
Alabama (86)
Alaska (7)
Arizona (315)
Arkansas (13)
Asia (39277)
Australia (6424)
California (11638)
Canada (3359)
China (1124)
Colorado (489)
Connecticut (490)
Delaware (343)
Europe (84750)
Florida (1752)
Georgia (372)
Hawaii (3)
Idaho (61)
Illinois (888)
India (71)
Indiana (538)
Iowa (22)
Japan (447)
Kansas (127)
Kentucky (42)
Louisiana (28)
Maine (72)
Maryland (1416)
Massachusetts (8313)
Michigan (336)
Minnesota (635)
Mississippi (6)
Missouri (129)
Montana (32)
Nebraska (29)
Nevada (126)
New Hampshire (80)
New Jersey (3096)
New Mexico (28)
New York (3058)
North Carolina (1489)
North Dakota (8)
Northern California (5720)
Ohio (346)
Oklahoma (21)
Oregon (41)
Pennsylvania (2345)
Puerto Rico (24)
Rhode Island (49)
South America (1108)
South Carolina (68)
South Dakota (1)
Southern California (4539)
Tennessee (179)
Texas (1787)
United States (41169)
Utah (350)
Vermont (1)
Virginia (270)
Washington D.C. (81)
Washington State (937)
West Virginia (4)
Wisconsin (112)
Wyoming (2)
723,251 Results for "medmira inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MedMira Reports First Quarter Results FY2026
December 30, 2025
·
6 min read
Press Releases
MedMira Reports FY2025 Fourth Quarter and Year End Financial Results
December 1, 2025
·
5 min read
Press Releases
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
February 26, 2025
·
4 min read
Press Releases
Health Canada Approves MedMira’s Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis
August 26, 2025
·
5 min read
Corporate Update on Clinical Evaluation of MedMira’s Products
MedMira Inc. is pleased to provide an update on the ongoing review process by Health Canada.
February 1, 2024
·
3 min read
Business
MedMira Announces the Hire of Vice President of Business Development
MedMira Inc. is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the position of Vice President of Business Development.
April 30, 2024
·
3 min read
Business
MedMira Reports Second Quarter Results FY2024
MedMira Inc., reported on its financial results for the quarter ended January 31, 2024.
April 1, 2024
·
4 min read
Press Releases
MedMira Reports Second Quarter Results FY2025
April 1, 2025
·
5 min read
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
MedMira Inc. announces the receipt of a Canadian patent patent for its new innovative and quantitative test system.
March 13, 2024
·
4 min read
Business
MedMira Reports First Quarter Results FY2024
MedMira Inc., reported on its financial results for the quarter ended October 31, 2023.
December 29, 2023
·
4 min read
1 of 72,326
Next
